Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
Follow us for updates on LinkedIn, Twitter, or Facebook. If you purchased or otherwise acquired GoodRx common stock during the Class Period, you may move the Court no later than June 21, 2024 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if ...